Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Bartels

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 16, 2022
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancerIsabel Grote, Stephan Bartels, Henriette Christgen, et al.
The Journal of Pathology. Clinical Research|December 31, 2020
Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breastMartin Radner, Jana Lisa van Luttikhuizen, Stephan Bartels, et al.
Human Mutation|April 14, 2025
A Novel <i>Alu</i> Element Insertion in <i>ATM</i> Induces Exon Skipping in Suspected HBOC PatientsJanin Klein, Aldrige B Allister, Gunnar Schmidt, et al.
The Journal of Pathology. Clinical Research|January 12, 2023
First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinomaOlaf Neumann, Ulrich Lehmann, Stephan Bartels, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2025
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle TrialMartin Radner, Sandy Burmeister, Katarzyna Jóźwiak, et al.
Hemasphere|March 11, 2025
Cell-free DNA for detection and monitoring of extramedullary AML relapseHenri C Hupe, Clara P Wienecke, Stephan Bartels, et al.
Cancer Medicine|November 15, 2021
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancerIsabel Grote, Stephan Bartels, Leonie Kandt, et al.
The Journal of Pathology. Clinical Research|April 15, 2024
Microenvironment-induced restoration of cohesive growth associated with focal activation of P-cadherin expression in lobular breast carcinoma metastatic to the colonMalte Gronewold, Isabel Grote, Stephan Bartels, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
Acta Neuropathologica|January 17, 2026
Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumorsFrank Brand, Lily S Rose, Amir H Akbarzadeh, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 16, 2022
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancerIsabel Grote, Stephan Bartels, Henriette Christgen, et al.
The Journal of Pathology. Clinical Research|December 31, 2020
Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breastMartin Radner, Jana Lisa van Luttikhuizen, Stephan Bartels, et al.
Human Mutation|April 14, 2025
A Novel <i>Alu</i> Element Insertion in <i>ATM</i> Induces Exon Skipping in Suspected HBOC PatientsJanin Klein, Aldrige B Allister, Gunnar Schmidt, et al.
The Journal of Pathology. Clinical Research|January 12, 2023
First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinomaOlaf Neumann, Ulrich Lehmann, Stephan Bartels, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2025
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle TrialMartin Radner, Sandy Burmeister, Katarzyna Jóźwiak, et al.
Hemasphere|March 11, 2025
Cell-free DNA for detection and monitoring of extramedullary AML relapseHenri C Hupe, Clara P Wienecke, Stephan Bartels, et al.
Cancer Medicine|November 15, 2021
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancerIsabel Grote, Stephan Bartels, Leonie Kandt, et al.
The Journal of Pathology. Clinical Research|April 15, 2024
Microenvironment-induced restoration of cohesive growth associated with focal activation of P-cadherin expression in lobular breast carcinoma metastatic to the colonMalte Gronewold, Isabel Grote, Stephan Bartels, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
Acta Neuropathologica|January 17, 2026
Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumorsFrank Brand, Lily S Rose, Amir H Akbarzadeh, et al.
Pageof 5